WO2000018916A3 - Human genes and gene expression products - Google Patents

Human genes and gene expression products Download PDF

Info

Publication number
WO2000018916A3
WO2000018916A3 PCT/US1999/022226 US9922226W WO0018916A3 WO 2000018916 A3 WO2000018916 A3 WO 2000018916A3 US 9922226 W US9922226 W US 9922226W WO 0018916 A3 WO0018916 A3 WO 0018916A3
Authority
WO
WIPO (PCT)
Prior art keywords
genes
gene expression
expression products
human genes
polynucleotides
Prior art date
Application number
PCT/US1999/022226
Other languages
French (fr)
Other versions
WO2000018916A2 (en
Inventor
Lewis T Williams
Jaime Escobedo
Michael A Innis
Pablo Dominguez Garcia
Julie Sudduth-Klinger
Christoph Reinhard
Klaus Giese
Filippo Randazzo
Giulia C Kennedy
David Pot
Altaf Kassam
George Lamson
Radoje Drmanac
Radomir Crkvenjakov
Mark Dickson
Snezana Drmanac
Ivan Labat
Dena Leshkowitz
David Kita
Veronica Garcia
Lee William Jones
Birgit Stache-Crain
Original Assignee
Chiron Corp
Hyseq Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp, Hyseq Inc filed Critical Chiron Corp
Priority to AU62639/99A priority Critical patent/AU6263999A/en
Priority to EP99949860A priority patent/EP1144636A2/en
Priority to JP2000572363A priority patent/JP2003530816A/en
Publication of WO2000018916A2 publication Critical patent/WO2000018916A2/en
Publication of WO2000018916A3 publication Critical patent/WO2000018916A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.
PCT/US1999/022226 1998-09-28 1999-09-23 Human genes and gene expression products WO2000018916A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU62639/99A AU6263999A (en) 1998-09-28 1999-09-23 Human genes and gene expression products
EP99949860A EP1144636A2 (en) 1998-09-28 1999-09-23 Human genes and gene expression products
JP2000572363A JP2003530816A (en) 1998-09-28 1999-09-23 Human genes and gene expression products

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US10216198P 1998-09-28 1998-09-28
US10218098P 1998-09-28 1998-09-28
US60/102,180 1998-09-28
US60/102,161 1998-09-28
US10238098P 1998-09-29 1998-09-29
US60/102,380 1998-09-29
US10381598P 1998-10-08 1998-10-08
US60/103,815 1998-10-08
US10587798P 1998-10-27 1998-10-27
US60/105,877 1998-10-28

Publications (2)

Publication Number Publication Date
WO2000018916A2 WO2000018916A2 (en) 2000-04-06
WO2000018916A3 true WO2000018916A3 (en) 2000-11-16

Family

ID=27537030

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/022226 WO2000018916A2 (en) 1998-09-28 1999-09-23 Human genes and gene expression products

Country Status (4)

Country Link
EP (1) EP1144636A2 (en)
JP (1) JP2003530816A (en)
AU (1) AU6263999A (en)
WO (1) WO2000018916A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511834B1 (en) 2000-03-24 2003-01-28 Millennium Pharmaceuticals, Inc. 32142,21481,25964,21686, novel human dehydrogenase molecules and uses therefor
US6627423B2 (en) 2000-03-24 2003-09-30 Millennium Pharmaceuticals, Inc. 21481, a novel dehydrogenase molecule and uses therefor
GB0106782D0 (en) * 2001-03-19 2001-05-09 Univ The Glasgow Polypeptides, methods and means
US7449548B2 (en) 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
DE102004023187A1 (en) * 2004-05-11 2005-12-01 Ganymed Pharmaceuticals Ag Identification of surface-associated antigens for tumor diagnosis and therapy
EP3112474A1 (en) * 2015-06-29 2017-01-04 Evonik Degussa GmbH Method of detecting avian necrotic enteritis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020798A1 (en) * 1991-05-24 1992-11-26 Genentech, Inc. HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2¿
WO1996030389A1 (en) * 1995-03-29 1996-10-03 Millenium Pharmaceuticals, Inc. Compositions for the diagnosis, prevention, and treatment of tumor progression
WO1999033982A2 (en) * 1997-12-23 1999-07-08 Chiron Corporation Human genes and gene expression products i

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020798A1 (en) * 1991-05-24 1992-11-26 Genentech, Inc. HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2¿
WO1996030389A1 (en) * 1995-03-29 1996-10-03 Millenium Pharmaceuticals, Inc. Compositions for the diagnosis, prevention, and treatment of tumor progression
WO1999033982A2 (en) * 1997-12-23 1999-07-08 Chiron Corporation Human genes and gene expression products i

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CARMECI ET AL: "Identification of a gene (GPR30) with homolgy to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer", GENOMICS,US,ACADEMIC PRESS, SAN DIEGO, vol. 45, no. 3, 1 November 1997 (1997-11-01), pages 607 - 617-17, XP002099963, ISSN: 0888-7543 *
YEATMAN, T.J. ET AL.: "Identification of a differentially expressed message associated with colon cancer liver metastasis using an improved method of differential display.", NUCLEIC ACIDS RESEARCH,GB,OXFORD UNIVERSITY PRESS, SURREY, vol. 23, no. 19, 1995, pages 4007 - 4008-8, XP002099962, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
WO2000018916A2 (en) 2000-04-06
EP1144636A2 (en) 2001-10-17
JP2003530816A (en) 2003-10-21
AU6263999A (en) 2000-04-17

Similar Documents

Publication Publication Date Title
WO1999038972A3 (en) Human genes and gene expression products ii
WO1999058675A3 (en) Human genes and gene expression products v
WO1999033982A3 (en) Human genes and gene expression products i
WO2002014500A3 (en) Human genes and gene expression products
WO2001066753A3 (en) Human genes and gene expression products
WO2000040614A3 (en) Characterization of the soc/crac calcium channel protein family
MXPA02011656A (en) Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods.
EP1005540A4 (en) Ikk-beta proteins, nucleic acids and methods
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
WO2001005825A3 (en) Nucleic acid sequences encoding putative angiopoietin proteins
WO1999064594A8 (en) Genes and gene expression products that are differentially regulated in prostate cancer
WO1999053040A3 (en) Human nucleic acid sequences from ovarian tumour tissue
WO2002044320A3 (en) Human elongase genes and uses thereof
WO2001068705A3 (en) Il-17 receptor like molecules and uses thereof
WO2001064877A3 (en) Human schizophrenia gene
WO2003050236A3 (en) Human genes and gene expression products isolated from human prostate
WO2000077239A3 (en) Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses
WO2000073323A3 (en) Adam polynucleotides and polypeptides
WO2000018916A3 (en) Human genes and gene expression products
WO2001072781A3 (en) Human genes and expression products
WO2001000643A3 (en) Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase
WO1999046375A3 (en) Human nucleic acid sequences from prostate tissue
WO2001014415A3 (en) Egfh2 genes and gene products
WO2002055700A3 (en) Human genes and gene expression products isolated from human prostate
WO1999046381A3 (en) Human fgf gene and gene expression products

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 572363

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999949860

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1999949860

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999949860

Country of ref document: EP